Literature DB >> 12176909

SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC.

Anita M Kant1, Pradip De, Xiaodong Peng, Taolin Yi, David J Rawlings, Jong Suk Kim, Donald L Durden.   

Abstract

Fcgamma receptor-mediated phagocytosis is a complex process involving the activation of protein tyrosine kinases, events that are potentially down-regulated by protein tyrosine phosphatases. We used the J774A.1 macrophage cell line to examine the roles played by the protein tyrosine phosphatase SHP-1 in the negative regulation of Fcgamma receptor-mediated phagocytosis. Stimulation with sensitized sheep red blood cells (sRBCs) induced tyrosine phosphorylation of CBL and association of CBL with CRKL. These events were completely or partially abrogated by PP1 or the heterologous expression of dominant-negative SYK, respectively. Heterologous expression of wild-type but not catalytically inactive SHP-1 also completely abrogated the phagocytosis of IgG-sensitized sRBCs. Most notably, overexpressed SHP-1 associates with CBL and this association led to CBL dephosphorylation, loss of the CBL-CRKL interaction, and the suppression of Rac activation. These data represent the first direct evidence that SHP-1 is involved in the regulation of Fcgamma receptor-mediated phagocytosis and suggest that activating signals mediated by SRC family kinases SYK, CBL, phosphatidyl inositol-3 (PI-3) kinase, and Rac are directly opposed by inhibitory signals through SHP-1.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12176909

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Recruitment of the cross-linked opsonic receptor CD32A (FcgammaRIIA) to high-density detergent-resistant membrane domains in human neutrophils.

Authors:  Emmanuelle Rollet-Labelle; Sébastien Marois; Kathy Barbeau; Stephen E Malawista; Paul H Naccache
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

2.  The inositol phosphatase SHIP-2 down-regulates FcgammaR-mediated phagocytosis in murine macrophages independently of SHIP-1.

Authors:  Jing Ai; Amita Maturu; Wesley Johnson; Yijie Wang; Clay B Marsh; Susheela Tridandapani
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

Review 3.  Fcgamma receptor signaling in phagocytes.

Authors:  Trupti Joshi; Jonathan P Butchar; Susheela Tridandapani
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

4.  Baseline mechanical characterization of J774 macrophages.

Authors:  Jonathan Lam; Marc Herant; Micah Dembo; Volkmar Heinrich
Journal:  Biophys J       Date:  2009-01       Impact factor: 4.033

Review 5.  Regulation of tyrosine phosphorylation in macrophage phagocytosis and chemotaxis.

Authors:  Haein Park; Dan Ishihara; Dianne Cox
Journal:  Arch Biochem Biophys       Date:  2011-02-26       Impact factor: 4.013

Review 6.  Macrophage phagocytosis: effects of environmental pollutants, alcohol, cigarette smoke, and other external factors.

Authors:  John Karavitis; Elizabeth J Kovacs
Journal:  J Leukoc Biol       Date:  2011-08-30       Impact factor: 4.962

7.  Central neuroinvasion and demyelination by inflammatory macrophages after peripheral virus infection is controlled by SHP-1.

Authors:  George P Christophi; Paul T Massa
Journal:  Viral Immunol       Date:  2009-12       Impact factor: 2.257

8.  Bordetella adenylate cyclase toxin is a unique ligand of the integrin complement receptor 3.

Authors:  Radim Osicka; Adriana Osickova; Shakir Hasan; Ladislav Bumba; Jiri Cerny; Peter Sebo
Journal:  Elife       Date:  2015-12-09       Impact factor: 8.140

9.  Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5.

Authors:  Aaron F Carlin; Yung-Chi Chang; Thomas Areschoug; Gunnar Lindahl; Nancy Hurtado-Ziola; Charles C King; Ajit Varki; Victor Nizet
Journal:  J Exp Med       Date:  2009-07-13       Impact factor: 14.307

10.  Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype.

Authors:  George P Christophi; Michael Panos; Chad A Hudson; Rebecca L Christophi; Ross C Gruber; Akos T Mersich; Scott D Blystone; Burk Jubelt; Paul T Massa
Journal:  Lab Invest       Date:  2009-04-27       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.